S.‐H. Kim

Mutation spectrum and inhibitor risk in 100 Korean patients with severe haemophilia A

S. Kim, H. Kim, H.S. Chung, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia

H. Kim, S.‐H. Kim, J. Kim, 2017, Leukemia.

Impact of Dialysis Modality on the Incidence of 2009 Pandemic H1N1 Influenza in End-Stage Renal Disease Patients

J.H. Cho, Chan-Duck Kim, K. Cho, 2011, Peritoneal Dialysis International.

Genetic basis of Prader–Willi syndrome in Korea: less uniparental disomy than has been recognized?

C. Ki, H. Kim, S.‐H. Kim, 2004, Clinical genetics.

Infectious complications following allogeneic stem cell transplantation: reduced‐intensity vs. myeloablative conditioning regimens

S. Lee, S. Park, S.‐H. Kim, 2013, Transplant infectious disease : an official journal of the Transplantation Society.

Infectious complications associated with alemtuzumab use for allogeneic hematopoietic stem cell transplantation: comparison with anti‐thymocyte globulin

Jun-Sub Choi, S. Park, S.‐H. Kim, 2009, Transplant infectious disease : an official journal of the Transplantation Society.

Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia.

C. Choi, H. Eom, H. Yhim, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Pretransplant imatinib can improve the outcome of nonmyeloablative stem cell transplantation without increasing the morbidity in Philadelphia chromosome-positive chronic myeloid leukemia

J. W. Lee, H. Kim, S. Lee, 2004, Leukemia.

Prevalence of type 5 familial hemophagocytic lymphohistiocytosis in Korea and novel mutations in STXBP2

H. Koo, K. Yoo, K. Sung, 2016, Clinical genetics.